¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04
±³À°ÀÏÀÚ : 2021-12-04
±³À°Àå¼Ò : Ãµ¾È ½Å¶ó½ºÅ×ÀÌ  
±³À°ÁÖÁ¦ : Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺ¹¸·¾ÏÇÐȸ  
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 041-529-6186  
À̸ÞÀÏ : office@kspsm.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : Ãæû³²µµ
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï: 4¸¸¿ø ÇöÀåµî·Ï: 5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:10~09:30 Anatomy and physiology of the peritoneum  ¾Èżº(¼øõÇâ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:30~09:50 Peri-operative management to pervent complications  À̼ºÃ¶(´Ü±¹´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:50~10:10 Immunological importance in peritoneal surface malignancy  ±è¿ì¶÷(Â÷ÀÇ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:10~10:30 Micro-tumor environment changes in advanced and recurrent epithelial ovarian cancer  ÀÌÁ¤À±(¿¬¼¼´ë) 
È޽Ġ12-04 ½Å¶ó½ºÅ×ÀÌ 10:30~10:50 Break time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:50~11:10 Principles in the treatment of colorectal cancer with peritoneal metastasis  ¹é½ÂÇõ(¿¬¼¼´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:10~11:30 Update in PMCR from surgical point of view  ¹Ú¼ö¿¬(°æºÏ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:30~11:50 Update in PMCR from oncological point of view  ¹Ú¿µ¼®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:50~12:10 Update in appendiceal cancer from pathological point of view  ÀÌ¿ø¾Ö(´Ü±¹´ë) 
½Ä»ç 12-04 ½Å¶ó½ºÅ×ÀÌ 12:10~13:00 Lunch Time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:00~13:30 Future perspective of the CRS/HIPEC as treatment modality for peritoneal surface malignancy  ¹Úµ¿±¹(´Ü±¹´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:30~13:50 HIPEC/IP Chemotherapy Treatment Strategy with changing paradigm of molecular/immune therapy in frontline treatment of OC  ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:50~14:10 Surgery and HIPEC with changing paractice of melecular/immune therapy in recurrent OC  Àå¼®ÁØ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:10~14:30 Recent advancement of HIPEC protocols in ovarian cancer  ¼Û¿ëÁß(ºÎ»ê´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:30~14:50 Novel Clinical trials of HIPEC in peritoneal metastases from gynecologic malignancy  Dr. Sonke(Netherlands-¾Ï¼¾ÅÍ) 
È޽Ġ12-04 ½Å¶ó½ºÅ×ÀÌ 14:50~15:10 Break Time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:10~15:30 CT-Based Model to Predict Peritoneal Metastasis from Gastric Cancer  Á¤¿ì°æ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:30~15:50 An Innovative Method of Treatment for Peritoneal Carcinomatosis in Gastric Cancer  ¹Î»çÈ«(Ãæ³²´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:50~16:10 Intraperitoneal Chemotherapy for Peritoneal Metastasis in Gastric Cancer  ±èÁ¾ÇÑ(°í·Á´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 16:10~16:30 Update of HIPEC(Hyperthermic Intraperitoneal Chemotherapy) for Gastric Cancer  Áö¿¹¼·(´Ü±¹´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021 ´ëÇѺñ¸¸ÇÐȸ ºÎ»ê°æ³²Áöȸ ¿Â,¿ÀÇÁ¶óÀÎ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2021-12-04
´ÙÀ½±Û (¿Â¶óÀÎ) Çѱ¹È£½ºÇǽº¡¤¿ÏÈ­ÀÇ·áÇÐȸ 2021 Á¤±âÃÑȸ ¹× µ¿°èÇмú´ëȸ : 2021-12-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 16 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 26 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 13 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 15 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 10 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 14 2024-05-28
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 12 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 32 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷